National Bank Of Canada Beam Therapeutics Inc. Transaction History

National Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$21.22 - $32.66 $42,440 - $65,319	2,000 Added 200.0%	3,000 $70,000
Q1 2024 May 13, 2024	SELL	$23.46 - $45.07 $11,730 - $22,535	-500 Reduced 33.33%	1,000 $33,000
Q4 2023 Feb 06, 2024	BUY	$17.69 - $30.76 $17,690 - $30,760	1,000 Added 200.0%	1,500 $40,000
Q3 2023 Oct 10, 2023	BUY	$23.01 - $32.46 $11,505 - $16,230	500 New	500 $12,000
Q4 2022 Jan 24, 2023	BUY	$36.73 - $51.6 $7,345 - $10,320	200 Added 50.0%	600 $0
Q3 2022 Oct 13, 2022	SELL	$39.79 - $70.31 $7,958 - $14,062	-200 Reduced 33.33%	400 $19,000
Q2 2022 Jul 28, 2022	BUY	$29.86 - $62.36 $17,916 - $37,416	600 New	600 $23,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.04B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.